BACKGROUND: Many decisions in health care aim to maximise health, requiring judgements about interventions that may have higher health effects but potentially incur additional costs (cost-effectiveness framework). The evidence used to establish cost-effectiveness is typically uncertain and it is important that this uncertainty is characterised. In situations in which evidence is uncertain, the experience of experts is essential. The process by which the beliefs of experts can be formally collected in a quantitative manner is structured expert elicitation. There is heterogeneity in the existing methodology used in health-care decision-making. A number of guidelines are available for structured expert elicitation; however, it is not clear if any of these are appropriate for health-care decision-making. OBJECTIVES: The overall aim was to establish a protocol for structured expert elicitation to inform health-care decision-making. The objectives are to (1) provide clarity on methods for collecting and using experts' judgements, (2) consider when alternative methodology may be required in particular contexts, (3) establish preferred approaches for elicitation on a range of parameters, (4) determine which elicitation methods allow experts to express uncertainty and (5) determine the usefulness of the reference protocol developed. METHODS: A mixed-methods approach was used: systemic review, targeted searches, experimental work and narrative synthesis. A review of the existing guidelines for structured expert elicitation was conducted. This identified the approaches used in existing guidelines (the 'choices') and determined if dominant approaches exist. Targeted review searches were conducted for selection of experts, level of elicitation, fitting and aggregation, assessing accuracy of judgements and heuristics and biases. To sift through the available choices, a set of principles that underpin the use of structured expert elicitation in health-care decision-making was defined using evidence generated from the targeted searches, quantities to elicit experimental evidence and consideration of constraints in health-care decision-making. These principles, including fitness for purpose and reflecting individual expert uncertainty, were applied to the set of choices to establish a reference protocol. An applied evaluation of the developed reference protocol was also undertaken. RESULTS: For many elements of structured expert elicitation, there was a lack of consistency across the existing guidelines. In almost all choices, there was a lack of empirical evidence supporting recommendations, and in some circumstances the principles are unable to provide sufficient justification for discounting particular choices. It is possible to define reference methods for health technology assessment. These include a focus on gathering experts with substantive skills, eliciting observable quantities and individual elicitation of beliefs. Additional considerations are required for decision-makers outside health technology assessment, for example at a local level, or for early technologies. Access to experts may be limited and in some circumstances group discussion may be needed to generate a distribution. LIMITATIONS: The major limitation of the work conducted here lies not in the methods employed in the current work but in the evidence available from the wider literature relating to how appropriate particular methodological choices are. CONCLUSIONS: The reference protocol is flexible in many choices. This may be a useful characteristic, as it is possible to apply this reference protocol across different settings. Further applied studies, which use the choices specified in this reference protocol, are required. FUNDING: This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 25, No. 37. See the NIHR Journals Library website for further project information. This work was also funded by the Medical Research Council (reference MR/N028511/1).
BACKGROUND: Many decisions in health care aim to maximise health, requiring judgements about interventions that may have higher health effects but potentially incur additional costs (cost-effectiveness framework). The evidence used to establish cost-effectiveness is typically uncertain and it is important that this uncertainty is characterised. In situations in which evidence is uncertain, the experience of experts is essential. The process by which the beliefs of experts can be formally collected in a quantitative manner is structured expert elicitation. There is heterogeneity in the existing methodology used in health-care decision-making. A number of guidelines are available for structured expert elicitation; however, it is not clear if any of these are appropriate for health-care decision-making. OBJECTIVES: The overall aim was to establish a protocol for structured expert elicitation to inform health-care decision-making. The objectives are to (1) provide clarity on methods for collecting and using experts' judgements, (2) consider when alternative methodology may be required in particular contexts, (3) establish preferred approaches for elicitation on a range of parameters, (4) determine which elicitation methods allow experts to express uncertainty and (5) determine the usefulness of the reference protocol developed. METHODS: A mixed-methods approach was used: systemic review, targeted searches, experimental work and narrative synthesis. A review of the existing guidelines for structured expert elicitation was conducted. This identified the approaches used in existing guidelines (the 'choices') and determined if dominant approaches exist. Targeted review searches were conducted for selection of experts, level of elicitation, fitting and aggregation, assessing accuracy of judgements and heuristics and biases. To sift through the available choices, a set of principles that underpin the use of structured expert elicitation in health-care decision-making was defined using evidence generated from the targeted searches, quantities to elicit experimental evidence and consideration of constraints in health-care decision-making. These principles, including fitness for purpose and reflecting individual expert uncertainty, were applied to the set of choices to establish a reference protocol. An applied evaluation of the developed reference protocol was also undertaken. RESULTS: For many elements of structured expert elicitation, there was a lack of consistency across the existing guidelines. In almost all choices, there was a lack of empirical evidence supporting recommendations, and in some circumstances the principles are unable to provide sufficient justification for discounting particular choices. It is possible to define reference methods for health technology assessment. These include a focus on gathering experts with substantive skills, eliciting observable quantities and individual elicitation of beliefs. Additional considerations are required for decision-makers outside health technology assessment, for example at a local level, or for early technologies. Access to experts may be limited and in some circumstances group discussion may be needed to generate a distribution. LIMITATIONS: The major limitation of the work conducted here lies not in the methods employed in the current work but in the evidence available from the wider literature relating to how appropriate particular methodological choices are. CONCLUSIONS: The reference protocol is flexible in many choices. This may be a useful characteristic, as it is possible to apply this reference protocol across different settings. Further applied studies, which use the choices specified in this reference protocol, are required. FUNDING: This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 25, No. 37. See the NIHR Journals Library website for further project information. This work was also funded by the Medical Research Council (reference MR/N028511/1).
Authors: Laura Bojke; Bogdan Grigore; Dina Jankovic; Jaime Peters; Marta Soares; Ken Stein Journal: Pharmacoeconomics Date: 2017-09 Impact factor: 4.981
Authors: C McKenna; C McDaid; S Suekarran; N Hawkins; K Claxton; K Light; M Chester; J Cleland; N Woolacott; M Sculpher Journal: Health Technol Assess Date: 2009-04 Impact factor: 4.014
Authors: Matt D Stevenson; Jeremy E Oakley; Myfawny Lloyd Jones; Alan Brennan; Juliet E Compston; Eugene V McCloskey; Peter L Selby Journal: Med Decis Making Date: 2009-06-09 Impact factor: 2.583
Authors: Peter F Thall; Moreno Ursino; Véronique Baudouin; Corinne Alberti; Sarah Zohar Journal: Stat Methods Med Res Date: 2017-09-05 Impact factor: 3.021
Authors: Ashley A Leech; Pei-Jung Lin; Brittany D'Cruz; Susan K Parsons; Tara A Lavelle Journal: Appl Health Econ Health Policy Date: 2022-08-23 Impact factor: 3.686
Authors: Hamed Ekhtiari; Peyman Ghobadi-Azbari; Axel Thielscher; Andrea Antal; Lucia M Li; A Duke Shereen; Yuranny Cabral-Calderin; Daniel Keeser; Til Ole Bergmann; Asif Jamil; Ines R Violante; Jorge Almeida; Marcus Meinzer; Hartwig R Siebner; Adam J Woods; Charlotte J Stagg; Rany Abend; Daria Antonenko; Tibor Auer; Marc Bächinger; Chris Baeken; Helen C Barron; Henry W Chase; Jenny Crinion; Abhishek Datta; Matthew H Davis; Mohsen Ebrahimi; Zeinab Esmaeilpour; Brian Falcone; Valentina Fiori; Iman Ghodratitoostani; Gadi Gilam; Roland H Grabner; Joel D Greenspan; Georg Groen; Gesa Hartwigsen; Tobias U Hauser; Christoph S Herrmann; Chi-Hung Juan; Bart Krekelberg; Stephanie Lefebvre; Sook-Lei Liew; Kristoffer H Madsen; Rasoul Mahdavifar-Khayati; Nastaran Malmir; Paola Marangolo; Andrew K Martin; Timothy J Meeker; Hossein Mohaddes Ardabili; Marius Moisa; Davide Momi; Beni Mulyana; Alexander Opitz; Natasza Orlov; Patrick Ragert; Christian C Ruff; Giulio Ruffini; Michaela Ruttorf; Arshiya Sangchooli; Klaus Schellhorn; Gottfried Schlaug; Bernhard Sehm; Ghazaleh Soleimani; Hosna Tavakoli; Benjamin Thompson; Dagmar Timmann; Aki Tsuchiyagaito; Martin Ulrich; Johannes Vosskuhl; Christiane A Weinrich; Mehran Zare-Bidoky; Xiaochu Zhang; Benedikt Zoefel; Michael A Nitsche; Marom Bikson Journal: Nat Protoc Date: 2022-02-04 Impact factor: 17.021
Authors: Victoria Federico Paly; Murat Kurt; Lirong Zhang; Marcus O Butler; Olivier Michielin; Adenike Amadi; Emma Hernlund; Helen M Johnson; Srividya Kotapati; Andriy Moshyk; John Borrill Journal: MDM Policy Pract Date: 2022-03-26
Authors: Dieter Ayers; Shannon Cope; Kevin Towle; Ali Mojebi; Thomas Marshall; Devender Dhanda Journal: BMC Med Res Methodol Date: 2022-10-15 Impact factor: 4.612